Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-ranging study of KHK4563 in adults with uncontrolled suspected eosinophilic asthma
KCT0000178Phase 2Recruiting
- Sponsor
- Jeil-Kirin Pharmaceutical
- Start
- Sep 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of benralizumab in asthma, sponsored by Jeil-Kirin Pharmaceutical. Started Sep 2011; status: recruiting.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on KCT0000178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000178.